• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Layoffs
Biotech

Pressure of biopharma layoffs continues to ease in Q2'26

A sharp reduction in layoffs continued in the second quarter, extending a trend that started last fall, an analysis of Fierce data has revealed.
Will Maddox Jul 1, 2026 10:30am
Model of human skeleton

Bain-backed Angitia drops lead spinal fusion candidate

Jun 30, 2026 4:56pm
Deal

Ipsen pens €700M deal to buy Swiss biotech for rare disease drug

Jul 1, 2026 8:05am
A photo finish at a horse race with both horses crossing the finish line

China approved the first solid tumor CAR-T. Will the US follow?

Jun 30, 2026 10:00am
brain

Merck halts ph. 2 Alzheimer’s trial after underwhelming efficacy

Jul 1, 2026 2:35pm
Brain

Backed by top VCs, biotech bags Alzheimer’s med in $2.2B deal

Jul 1, 2026 4:40am
More News

FDA gene therapy regulator steps down from leadership role

Jun 30, 2026 10:36am

Abivax stock rebounds on colitis prospect safety data

Jun 30, 2026 10:27am

Vistagen fails another phase 3 anxiety trial, spies path forward

Jun 30, 2026 9:48am

Deerfield’s Boulevard Bio pens $1.6B deal for trispecific TCE

Jun 30, 2026 8:00am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings